2020
DOI: 10.1080/13543776.2020.1776263
|View full text |Cite
|
Sign up to set email alerts
|

An overview of ghrelinO-acyltransferase inhibitors: a literature and patent review for 2010-2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 155 publications
0
13
0
1
Order By: Relevance
“…Despite the role of the ghrelin system in stress-related psychiatric disorders is not fully resolved yet, it provides a new and interesting vantage point in the search for more efficient diagnostic and therapeutic strategies (also see Figure 1). It remains unknown whether a modulation of the ghrelin system could be beneficial in the treatment of stress-related psychiatric disorders, however multiple pharmacological tools to do so have become available over the last two decades (McGovern et al, 2016;Lee et al, 2020;Moose et al, 2020). This includes GHSR agonists and antagonists as well as inverse agonists and GOAT inhibitors, although no authorized medicine is commercially available to date.…”
Section: Therapeutic Potential Of Targeting the Ghrelin System In Strmentioning
confidence: 99%
“…Despite the role of the ghrelin system in stress-related psychiatric disorders is not fully resolved yet, it provides a new and interesting vantage point in the search for more efficient diagnostic and therapeutic strategies (also see Figure 1). It remains unknown whether a modulation of the ghrelin system could be beneficial in the treatment of stress-related psychiatric disorders, however multiple pharmacological tools to do so have become available over the last two decades (McGovern et al, 2016;Lee et al, 2020;Moose et al, 2020). This includes GHSR agonists and antagonists as well as inverse agonists and GOAT inhibitors, although no authorized medicine is commercially available to date.…”
Section: Therapeutic Potential Of Targeting the Ghrelin System In Strmentioning
confidence: 99%
“…Additional data from longitudinal studies with larger samples could highlight specific patterns and associations of this hormone with psychopathology and behaviors during the course of treatment and recovery, eventually supporting the use of ghrelin assessment in clinical practice for a better characterization of EDs. Finally, targeted pharmacological interventions could be used in patients with a history of childhood trauma, such as ghrelin O‐acyltransferase inhibitors (Moose et al., 2020), to modulate reward circuits and reduce pathological behaviors.…”
Section: Discussionmentioning
confidence: 99%
“…Next, the ghrelin O-acyltransferase (GOAT) enzyme acylates or, more specifically, octanoylates proghrelin at the serine-3 residue, and the mature, 28-amino acid ghrelin is secreted [ 43 ]. Acyl ghrelin (AG) and desacyl ghrelin (DAG) can both be found in the blood stream, but only AG is capable of high-affinity binding to the growth hormone secretagogue receptor (GHSR) [ 49 , 50 ].…”
Section: Ghrelin and The Ghrelin Receptormentioning
confidence: 99%